In this report, we develop a novel active immunization strategy in a preclinical CADASIL model and demonstrate its ability to prevent NOTCH3 ECD aggregation, which is a key hallmark of CADASIL pathophysiology. The gene discussed is NOTCH3; the disease is CADASIL.